Monte Rosa Therapeutics, Inc. (GLUE)

NASDAQ: GLUE · Real-Time Price · USD

17.92

-0.58 (-3.14%)

At close: Feb 13, 2026, 4:00 PM EST

17.85

-0.07 (-0.39%)

After-hours: Feb 13, 2026, 7:34 PM EST

Monte Rosa Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 13, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	1,419	426	283	368	950	-
Market Cap Growth	258.15%	50.74%	-23.21%	-61.22%	-	-
Enterprise Value	1,068	228	151	142	583	-
Last Close Price	17.92	6.94	5.65	7.61	20.42	-
PS Ratio	8.12	5.64	-	-	-	-
PB Ratio	4.50	1.91	1.58	1.36	2.73	-
P/TBV Ratio	5.77	1.91	1.58	1.36	2.73	-
P/FCF Ratio	9.79	11.22	-	-	-	-
P/OCF Ratio	9.52	10.15	-	-	-	-
EV/Sales Ratio	5.88	3.01	-	-	-	-
EV/FCF Ratio	7.37	6.00	-	-	-	-
Debt / Equity Ratio	0.16	0.19	0.26	0.17	-	-
Debt / FCF Ratio	0.28	1.12	-	-	-	-
Asset Turnover	0.47	0.20	-	-	-	-
Quick Ratio	6.45	2.37	5.00	10.58	20.80	1.43
Current Ratio	6.54	2.40	5.07	10.79	20.96	1.49
Return on Equity (ROE)	9.28%	-36.15%	-60.07%	-35.06%	-40.35%	-277.72%
Return on Assets (ROA)	1.37%	-13.66%	-27.72%	-19.82%	-21.92%	-57.90%
Return on Capital Employed (ROCE)	2.10%	-28.80%	-55.70%	-35.50%	-20.80%	-139.30%
Earnings Yield	1.48%	-17.05%	-47.85%	-29.46%	-7.79%	-
FCF Yield	10.22%	8.91%	-22.22%	-28.61%	-7.28%	-
Buyback Yield / Dilution	-22.34%	-43.80%	-8.83%	-88.91%	-1548.09%	-7.11%

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q